India is taking a decisive step toward strengthening its domestic pharmaceutical supply chain with the foundation of a Rs 600 crore manufacturing facility in Kathua district of Jammu and Kashmir. The project, developed by Orchid Pharma with support from the Biotechnology Industry Research Assistance Council under the Department of Biotechnology, will produce Amino Cephalosporanic Acid (ACA), a vital intermediate used in cephalosporin antibiotics.